Margherita Moro1, Lucia Moletta1, Stella Blandamura2, Cosimo Sperti1
1Fourth Surgical Clinic, Department of Surgery, and 2Department of Pathology; University of Padua. Padua, Italy
Received February 24th, 2011 - Accepted April 15th, 2011
Context Acinar cell carcinoma is a rare pancreatic malignant tumor, which can be associated with a particular manifestation: pancreatic panniculitis. It presents with erythematous subcutaneous nodules located mainly on the legs. The skin lesions can precede, be concurrent with or follow the pancreatic illness. The pathogenesis is not fully understood, but it is believed to be associated with high levels of serum lipase produced by the neoplasm, causing fat necrosis in tissues. The treatment of pancreatic panniculitis is directed at the underlying pancreatic disease, which may result in regression of the skin lesions. We report a case of pancreatic acinar cell carcinoma associated with subcutaneous panniculitis together with a review of the English literature. Case report A 79-year-old woman, with a 13-month history of acute pancreatitis, asthenia, weight loss, and the CT finding of a mass in the pancreatic head, presented complaining of multiple, migrant and painful subcutaneous nodules on her lower extremities. High serum lipase levels were also present. She underwent a pancreaticoduodenectomy, with subsequent regression of the skin lesions and normalization of her serum lipase levels. Histology revealed an acinar cell carcinoma of the pancreas. Liver metastases occurred six months after surgery, and the patient underwent chemotherapy with gemcitabine. She is still alive 14 months after the initial surgery. Conclusions Although rare, the association between acinar cell carcinoma and pancreatic panniculitis has been described in the literature. In a patient with subcutaneous nodules, the presence of acinar cell carcinoma should be considered in order to prevent long delays in the diagnosis and treatment of this pancreatic malignancy.
Carcinoma, Acinar Cell; Pancreas; Pancreatectomy; Panniculitis
Subcutaneous panniculitis is a rare cutaneous eruption associated with pancreatic disease in 0.3-3% of cases . Acinar cell carcinoma is a very rare malignant tumor, accounting for approximately 1-2% of primary pancreatic neoplasms [2, 3]. Although acinar pancreatic carcinoma is present in a small proportion of patients with pancreatic cancer, more than one-half of those with subcutaneous fat necrosis have this type of pancreatic malignancy . Pancreatic panniculitis presents with ill-defined erythematous subcutaneous nodules located mainly on the legs. It may be associated with arthropathy, synovitis, osteolytic bone lesions and polyserositis. The pathogenesis of pancreatic panniculitis is still unknown, but it is believed to be associated with high levels of serum lipase produced by the neoplasm, causing fat necrosis in tissues .
We present the case of a 79-year-old woman with pancreatic acinar cell carcinoma who developed subcutaneous panniculitis on both legs.
In October 2008, a 79-year-old woman presented with an episode of acute pancreatitis and she was admitted to another hospital. Abdominal CT scan revealed an enlarged pancreatic head with the presence of an inhomogeneous, hypodense area in the uncinate process 1.5x3.0 cm in diameter. Tumor markers, including carcinoembryonic antigen (CEA) and CA 19- 9, were within the normal range. A cytologic sample derived from fine-needle percutaneous aspiration of the pancreas was inconclusive. The pancreatic lesion was interpreted as a consequence of the acute pancreatitis, and was not confirmed at a CT scan performed 3 months later.
In February 2009, the patient underwent a radical left mastectomy and right quadrantectomy for bilateral mammary invasive carcinoma (pT2 N1 M0; grade 2), followed by adjuvant radiotherapy and hormonal therapy. During the follow-up, an abdominal CT scan (August 2009) revealed a solid, ovoidal lesion (6.5x4.0 cm in diameter) in the pancreatic head, involving the uncinate process.
She underwent upper digestive endoscopy and endoscopic ultrasound (EUS) which revealed the presence of a large, solid mass localized in the pancreatic head, infiltrating the duodenal wall. A cytological examination of the lesion under EUS guidance was negative for neoplastic cells. A new CT scan revealed an enlargement of the pancreatic mass (9x5x8 cm in diameter) with infiltration of the duodenum (Figure 1).
In October 2009, the patient complained of multiple painful migrant nodules, with erythematous skin, on her lower extremities which were explained as erythema nodosum or paraneoplastic syndrome (Figure 2). The patient was treated with steroids, without benefit.
In November 2009, after a second episode of acute pancreatitis, the patient was referred to our department. Laboratory investigations showed a hemoglobin concentration of 8.3 g/dL (reference range: 14.0-17.5 g/dL), amylase of 113 U/L (reference range: 0-53 U/L) and lipase of 1,508 U/L (reference range: 0-60 U/L). CEA, CA 19-9 and alpha-fetoprotein were within the normal range. Upper digestive endoscopy confirmed the presence of an ulcerated mass infiltrating the second duodenal portion, with evidence of recent bleeding. The endoscopic biopsy of the mass was positive for adenocarcinoma (grade 2-3) of pancreatic origin with widespread necrotic areas. A biopsy of the subcutaneous nodule confirmed the presence of areas of necrotic subcutaneous fat surrounded by chronic inflammation consistent with pancreatic panniculitis (Figure 3).
In December 2009, the patient underwent a pyloruspreserving pancreaticoduodenectomy. Histopathological examination showed an acinar cell carcinoma with angiolymphatic invasion and infiltration of the duodenal wall (pT3 N0 M0; R0) (Figure 4). After surgery, there was regression of the subcutaneous nodules (Figure 5) with normalization of the serum lipase levels.
The postoperative course was complicated by a biliary and enterocutaneous fistula which was successfully treated with percutaneous drainage under radiologic guidance. A PET/CT scan carried out in June 2010 revealed the presence of multiple liver metastases. Serum lipase levels were 241 U/L. The patient underwent chemotherapy with gemcitabine, and she is still alive 14 months after resection.
Panniculitis is defined as a painful cutaneous nodule which arises from an inflammatory reaction in the subcutaneous fat in association with erythema nodosum, erythema induratum, Weber-Christian panniculitis, lupus panniculitis, alpha-1-antitrypsin deficiency and pancreatic disease including pancreatic neoplasm . The association between pancreatic disease and subcutaneous fat necrosis was first described by Chiari in 1883 . When associated with a pancreatic tumor, the combination of subcutaneous fat necrosis, polyarthritis and eosinophilia is known as Schmid’s triad . The skin manifestation can precede, occur concurrently with or follow the pancreatic pathology [9, 10]. The subcutaneous nodules associated with pancreatic disease may be painful or painless. They may occur anywhere but most commonly develop on the lower legs . The clinical presentation of panniculitis includes erythematous, illdefined reddish-brown nodules which can also appear on the arms, trunk, thighs and breast. Distinctive laboratory values include eosinophilia and elevated serum lipase levels . The pathogenesis of pancreatic panniculitis is not fully understood, but it is thought to result from the saponification of fat secondary to the action of liberated pancreatic lipase and elastase I . Pancreatic panniculitis is characterized histopathologically by lobular fat necrosis with anuclear adipocytes, called ghost cells, within a thick, shadowy wall. Focal calcification and a mixed inflammatory infiltrate may also be seen .
Pancreatic panniculitis can be associated with pancreatic malignant tumors (acinar cell carcinoma in 80% of the cases), and with acute or chronic pancreatitis . Acinar cell carcinoma accounts for only 1% of all pancreatic tumors. It is defined as a carcinoma exhibiting pancreatic enzyme production by neoplastic exocrine cells, and its clinical presentation is usually related either to the local effects of the tumor or to metastasis . It occurs predominantly in middleaged people (male:female ratio of 2:1), but can also occur in the pediatric population . The presenting symptoms are usually nonspecific. The most common presentation is abdominal pain, with a palpable abdominal mass. Jaundice is infrequent . Acinar cell carcinoma may induce local, regional and focally disseminated fat necrosis. Klimstra et al.  reported panniculitis and high serum lipase levels in 14% (4/28) of cases of pancreatic acinar cell carcinoma. In our patient, there was a diagnostic delay of more than one year between the first episode of pancreatitis and surgical treatment; an attempt to obtain a cytological diagnosis under endoscopic ultrasound guidance (EUSFNA) was unsuccessful, although EUS-FNA has been considered a highly sensitive and specific method for the preoperative work-up of pancreatic masses. Nevertheless, false negative results may occur, depending on the tumor diameter, number of tissue samples and expertise of the operator. He pancreatic panniculitis appeared one year after the onset of symptoms. Clinicians should be aware that panniculitis may be the sentinel of serious pancreatic disease, such as pancreatic cancer, and may precede the usual manifestations of these conditions . Only a minority of cases of subcutaneous panniculitis are associated with pancreatic disease. However, in the presence of a pancreatic mass, as in our case, the diagnosis of acinar cell carcinoma should strongly be considered. The treatment of pancreatic panniculitis consists of surgical intervention, whenever possible, which may lower lipase levels and result in regression of the skin lesions . The prognosis of acinar cell carcinoma is generally considered poor, although better survival as compared to ductal adenocarcinoma has also been reported [2, 3, 15].
In a review of the literature, we found 15 cases (including our patient) of acinar cell carcinoma and subcutaneous panniculitis [4, 9, 10, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25] (Table 1). There were 12 males, and the mean age at presentation was 63.0 years (range: 59- 84 years). Pancreatic panniculitis occurred before the diagnosis of pancreatic cancer in 9 patients (at a median of 4 months, range: 1-12 months), was present at diagnosis in three patients, and occurred after diagnosis in one patient. In two patients, this information was lacking. In six cases, the tumor was located in the head of the pancreas; five tumors were metastatic and two were locally advanced at presentation. All patients presented with high serum lipase levels. Nine patients underwent a pancreatectomy, five chemo- or radio-therapy, and one supportive therapy only. There was one operative mortality. The follow-up was very short, ranging from 2 to 23 months; only four patients are alive (two with disease) 6, 12, 14, and 23 months after treatment, respectively. The presence of the subcutaneous manifestation seems to be associated with decreased survival, probably reflecting greater aggressiveness of the tumor. In the study of Klimstra et al. , mean survival of patients with lipase-secreting acinar cell carcinoma was 8.8 months, considerably worse than the survival of patients without the syndrome (20.0 months; P<0.05). In our case, the maximum tumor diameter increased from 3.0 to 9.0 cm after 11 months. So, the doubling time, based on the Schwartz formula  was 70 days, confirming the aggressive behavior of the neoplasm. Early recognition and neo-adjuvant therapy could be useful in improving the clinical management of this type of cancer.
In conclusion, acinar cell carcinoma is a rare tumor and its preoperative diagnosis is difficult. Although subcutaneous fat necrosis can occur late in the course of the disease, recognition of the association between subcutaneous panniculitis and a pancreatic neoplasm may prevent a long delay in the diagnosis and management of this malignancy.
The authors have no potential conflicts of interest
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : June 19, 2019